Table 3 Survival analyses of first-line therapeutics for Lyme disease using a propensity-score-matched cohort.

From: Lyme Disease Patient Trajectories Learned from Electronic Medical Data for Stratification of Disease Risk and Therapeutic Response

Medication

Disease (ICD9)

ICD9

P value (LogRank)

Hazard Ratio (90% CI)

P value (Cox)

Doxycycline

Tear film insuffic NOS

375.15

6.08E-02

2.65 (1.09–6.45)

7.13E-02

Doxycycline

Cataract NOS

366.9

6.72E-02

1.9 (1.06–3.42)

7.18E-02

Doxycycline

Chronic rhinitis

472.0

3.60E-02

0.49 (0.28–0.87)

3.99E-02

Doxycycline

Backache NOS

724.5

1.67E-02

0.42 (0.23–0.78)

2.03E-02

Amoxicillin

Acute URI NOS

465.9

7.41E-03

2.26 (1.35–3.78)

9.13E-03